Literature DB >> 2007815

Primary palmaris longus transfer as an opponensplasty in carpal tunnel release. A series of 73 cases.

G Foucher1, C Malizos, D Sammut, F M Braun, J Michon.   

Abstract

Seventy three Camitz-Littler operations combining carpal tunnel release and palmaris longus oppenens transfer provided 90.7% good long term results. A technical modification can provide pronation.

Entities:  

Mesh：

Year:  1991        PMID： 2007815     DOI： 10.1016/0266-7681(91)90128-b

Source DB:  PubMed          Journal:  J Hand Surg Br        ISSN： 0266-7681


  6 in total

Review 1.  Carpal tunnel syndrome - Part II (treatment).

Authors:  Michel Chammas; Jorge Boretto; Lauren Marquardt Burmann; Renato Matta Ramos; Francisco Santos Neto; Jefferson Braga Silva
Journal:  Rev Bras Ortop       Date:  2014-08-23

2.  Biomechanical Evaluation of Opponensplasty for Low Median Palsy: A Cadaver Study.

Authors:  Maki Iwase; Yusuke Matsuura; Kazuki Kuniyoshi; Takane Suzuki; Kengo Nagashima; Seiji Ohtori
Journal:  J Hand Surg Glob Online       Date:  2021-01-17

Review 3.  Revision of Carpal Tunnel Surgery.

Authors:  Stahs Pripotnev; Susan E Mackinnon
Journal:  J Clin Med       Date:  2022-03-03       Impact factor: 4.241

4.  Modified Camitz versus BRAND Procedures for the Treatment of Severe Carpal Tunnel Syndrome: A Comparative Trial Study.

Authors:  Mohammad Dehghani; Behrooz Fadaei; Shirvan Rastegar; Abolghasem Zarezadeh; Keyvan Ghadimi; Roham Nikkhah; Sepehr Eslami
Journal:  Arch Bone Jt Surg       Date:  2020-05

5.  Evaluation of thenar muscles by MRI in carpal tunnel syndrome.

Authors:  Thitinut Dilokhuttakarn; Kiyohito Naito; Mayuko Kinoshita; Yoichi Sugiyama; Kenji Goto; Yoshiyuki Iwase; Kazuo Kaneko
Journal:  Exp Ther Med       Date:  2017-07-09       Impact factor: 2.447

6.  A new method of measuring the thumb pronation and palmar abduction angles during opposition movement using a three-axis gyroscope.

Authors:  Tomoyuki Kuroiwa; Koji Fujita; Akimoto Nimura; Takashi Miyamoto; Toru Sasaki; Atsushi Okawa
Journal:  J Orthop Surg Res       Date:  2018-11-16       Impact factor: 2.359
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.